Home
How It Works
Solutions
Resources
Events
Blog
Case Studies
For Academic Experts
Sign Up
Login

Work with thought leaders and academic experts in nephrology

Companies can greatly benefit from working with experts in the field of nephrology. These researchers bring a deep understanding of kidney diseases, treatments, and advancements. By collaborating with nephrology thought leaders, companies can enhance their research and development efforts, gain valuable insights into the latest trends and technologies, and accelerate innovation in the field. Whether it's developing new drugs, medical devices, or treatment protocols, partnering with nephrology experts can lead to breakthrough discoveries and improved patient outcomes.

Researchers on NotedSource with backgrounds in nephrology include Luke Connelly, Sheila Monfared, Ph.D., Kalpita R. Karan, Leo R Fitzpatrick PhD, Moji Ghadimi, Professor Esper A. Cavalheiro, Charles T. Hill, PhD, Xander van Wijk, PhD, DABCC, FADLM, Mohamad Hadla, Yasmeen George, Anil Kumar, Mehrdad Sheikhvatan, and Dr. Craig Pfeifer PhD, ATC, FHEA.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Nephrology
Other Research Interests (42)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 37 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (1+)

105 total publications

Geriatric CKD: Value-Based Nephrology

Advances in Chronic Kidney Disease / Jan 01, 2016

Yee, J. (2016). Geriatric CKD: Value-Based Nephrology. Advances in Chronic Kidney Disease, 23(1), 1–5. https://doi.org/10.1053/j.ackd.2015.11.001

See Full Profile

Sheila Monfared, Ph.D.

Specialist in Psychology, Human Factors, and Social Engineering: Delivering Impactful Research Solutions in academia and Industry
Most Relevant Research Interests
Nephrology
Other Research Interests (12)
Orthopedics and Sports Medicine
Physical Therapy, Sports Therapy and Rehabilitation
Applied Psychology
Experimental and Cognitive Psychology
Endocrine and Autonomic Systems
And 7 more
About
Sheila Monfared, Ph.D. is a seasoned researcher and consultant with specialized expertise in human factors and sports psychology. Her advanced degrees in Sports Psychology from Florida State University and Human Factors from Georgia Institute of Technology equip her with a unique skill set that bridges the gap between technology and human performance. Sheila's Master of Science in Kinesiology from Tehran University further complements her holistic approach to enhancing performance and mental health. In her professional career, Sheila has excelled in roles such as Strategic Planning Consultant at Saddleback College and Research Scientist at Innisghtful, focusing on research and interface design. Her extensive research experience in cognitive ergonomics and human-computer interaction allows her to provide tailored solutions to individuals and organizations. Sheila's passion lies in using her diverse knowledge to drive success and innovation. Whether optimizing sports performance or enhancing user experience, she is dedicated to helping clients reach their full potential.
Most Relevant Publications (1+)

6 total publications

A Bio-Physio-Psychological Investigation of Athletes’ Burnout

Research Quarterly for Exercise and Sport / Feb 28, 2020

Monfared, S. S., Lebeau, J.-C., Mason, J., Cho, S. K., Basevitch, I., Perry, I., Baur, D. A., & Tenenbaum, G. (2020). A Bio-Physio-Psychological Investigation of Athletes’ Burnout. Research Quarterly for Exercise and Sport, 92(1), 189–198. https://doi.org/10.1080/02701367.2020.1715911

See Full Profile

Kalpita R. Karan

Ph.D. with a over 8 years of experience in human genetics and molecular biology. Presently, pushing pre-clinical discovery pipelines in human gene therapy at Weill Cornell Medicine.
Most Relevant Research Interests
Nephrology
Other Research Interests (24)
AAV Gene therapy
Alzheimer's
Human Genetics
Mitochondria
Aging
And 19 more
About
PROFESSIONAL SUMMARY ■ Trained molecular geneticist with 10+ years of scientific and technical expertise in genetics and molecular biology. ■ Actively contributing to CNS gene therapy, specifically focused on Alzheimer’s disease. ■ Carry a vision that nucleic acid-based therapeutics are solutions to numerous health problems. ■ Believe that stress, inflammation, and disease risk are highly correlated and should be a focus of the therapeutic strategy.
Most Relevant Publications (1+)

23 total publications

Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood

Brain, Behavior, & Immunity - Health / May 01, 2020

Karan, K. R., Trumpff, C., McGill, M. A., Thomas, J. E., Sturm, G., Lauriola, V., Sloan, R. P., Rohleder, N., Kaufman, B. A., Marsland, A. L., & Picard, M. (2020). Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood. Brain, Behavior, & Immunity - Health, 5, 100080. https://doi.org/10.1016/j.bbih.2020.100080

See Full Profile

Leo R Fitzpatrick PhD

Greenwood , South Carolina, United States of America
GI Pharmacology and IBD Research Consultant
Most Relevant Research Interests
Nephrology
Other Research Interests (32)
Inflammatory Bowel Disease
Colitis
Arthritis
Surgery
Immunology
And 27 more
About
Please see my CV for details. I have 37 years of GI and IBD Research experience. This includes both industry and academic experience.
Most Relevant Publications (1+)

89 total publications

The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice

International Journal of Nephrology and Renovascular Disease / Nov 01, 2022

Maines, L. W., Green, C. L., Keller, S. N., Fitzpatrick, L. R., & Smith, C. D. (2022). The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice. International Journal of Nephrology and Renovascular Disease, Volume 15, 323–334. https://doi.org/10.2147/ijnrd.s386396

See Full Profile

Moji Ghadimi

Senior Research Fellow, University of Queensland
Most Relevant Research Interests
Nephrology
Other Research Interests (16)
Quantum Foundations
Experimental Quantum Physics
Computational Physics
Machine Learning
Statistical and Nonlinear Physics
And 11 more
About
My passion is to thoroughly understand complex systems to the level that I can explain them to anyone and use that deep understanding to improve them. I have experience in a wide variety of fields in industry and academia (Quantum Computing, AI, IT Management, etc.). With my interdisciplinary knowledge and experience, I have been able to transform the workplaces I worked in so that they continued to perform better even after I left the job. As one example, I can mention my previous job at Griffith University, where I used AI, optimization, and automation to improve the functionality of the quantum computer that my team worked on. Outside work, I spend time with my family, play soccer, or go hiking.
Most Relevant Publications (1+)

19 total publications

POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY

Kidney International Reports / Feb 01, 2022

ESCUDERO, A. E., Ferrer, F., & Pascual, C. (2022). POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY. Kidney International Reports, 7(2), S366–S367. https://doi.org/10.1016/j.ekir.2022.01.887

See Full Profile

Professor Esper A. Cavalheiro

Professor Emeritus at Departamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina/UNIFESP
Most Relevant Research Interests
Nephrology
Other Research Interests (58)
neurociência
Behavioral Neuroscience
Neurology
Neurology (clinical)
Cellular and Molecular Neuroscience
And 53 more
About
Esper A. Cavalheiro is a highly accomplished Brazilian scientist and medical professional. He holds a postdoctoral degree from Università degli Studi di Roma La Sapienza and CNRS - Gif-sur-Yvette, as well as a PhD from Universidade Federal de São Paulo and an MD from Universidade Federal de Sao Paulo, Escola Paulista de Medicina. With over 40 years of experience in the field, he is currently a Professor Emeritus at Universidade Federal de São Paulo. He is also a Full Professor at Universidade Federal de São Paulo Departamento de Neurologia e Neurocirurgia da UNIFESP. Professor Cavalheiro's research focuses on neurology and neurosurgery, and he has published numerous articles and books in these areas. He is highly regarded in the scientific community for his contributions to the field of epileptology and is a mentor to many young researchers.
Most Relevant Publications (2+)

406 total publications

Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution

Hemodialysis International / Oct 01, 2010

SCORZA, F. A., SCATTOLINI, M., CYSNEIROS, R. M., ARIDA, R. M., DE ALBUQUERQUE, M., TERRA, V. C., MACHADO, H. R., GOMES, R. A., KESROUANI, S., CRUZ, J., PELARIGO, F. C. M., SILVA, A. L., HENRIQUES, T. M. G., & CAVALHEIRO, E. A. (2010). Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution. Hemodialysis International, 14(4), 364–369. Portico. https://doi.org/10.1111/j.1542-4758.2010.00492.x

Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology

Nephrology Dialysis Transplantation / Feb 26, 2008

Scorza, F. A., Arida, R. M., & Cavalheiro, E. A. (2008). Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology. Nephrology Dialysis Transplantation, 23(5), 1775–1776. https://doi.org/10.1093/ndt/gfn017

See Full Profile

Charles T. Hill, PhD

Professor of Psychology at Whittier College
Research Interests (10)
Social Psychology
Diverse Identities
Anthropology
Developmental and Educational Psychology
Gender Studies
And 5 more
About
Dr. Hill's research focuses on intimate relationships, diverse identities, and well-being.

See Full Profile

Xander van Wijk, PhD, DABCC, FADLM

Strategic Leader in Clinical Diagnostics | Expert in Laboratory and Precision Medicine | Award-Winning Scientist & Author | CLIA Laboratory Director
Most Relevant Research Interests
Nephrology
Other Research Interests (40)
Clinical Chemistry
Cardiac Biomarkers
Analytical Toxicology
Pharmacogenomics
Blood Gas
And 35 more
About
A leader in the field of laboratory and precision medicine, passionate about improving healthcare through innovative solutions. Well versed in working in regulated environments (CLIA, FDA). Holding multiple board and leadership positions. Strong track record of scientific contributions with 70+ peer-reviewed articles, book chapters, and (inter)national podium presentations. Received several recent major awards & recognitions.
Most Relevant Publications (2+)

59 total publications

Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis

Kidney International / Nov 01, 2014

LWMM Rops, A., Loeven, M. A., van Gemst, J. J., Eversen, I., Van Wijk, X. M., Dijkman, H. B., van Kuppevelt, T. H., Berden, J. H. M., Rabelink, T. J., Esko, J. D., & van der Vlag, J. (2014). Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. Kidney International, 86(5), 932–942. https://doi.org/10.1038/ki.2014.115

Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease

Pediatric Nephrology / Nov 10, 2021

Lao, K., Sykes, E., van Wijk, X. M. R., Li, J., Williams, J., Gherasim, C., & Sun, Q. (2021). Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease. Pediatric Nephrology, 37(3), 677–681. https://doi.org/10.1007/s00467-021-05335-x

See Full Profile

Mohamad Hadla

Senior Research Fellow, Mayo Clinic
Most Relevant Research Interests
Nephrology
Other Research Interests (20)
Molecular Biology
Cancer Biology
Nanomedicine
Drug Delivery Systems
Biomedical Engineering
And 15 more
Most Relevant Publications (1+)

17 total publications

MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection

Nephrology Dialysis Transplantation / May 01, 2022

Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’arminio Monforte, A., Galassi, A., Tincati, C., Marchetti, G., & Gennaro Cozzolino, M. (2022). MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection. Nephrology Dialysis Transplantation, 37(Supplement_3). https://doi.org/10.1093/ndt/gfac070.023

See Full Profile

Yasmeen George

Lecturer - Faculty of IT at Monash University
Research Interests (23)
Artificial Intelligence
Deep/Machine Learning
Image/Data Analytics
Healthcare Analytics
Natural Language Processing
And 18 more
About
Yasmeen is a Lecturer with data science and AI department at Monash Faculty of Information Technology with over a decade of interdisciplinary research experience in AI for healthcare analytics. She received her Ph.D. from the University of Melbourne in 2018 (Australia). Her research focuses on the use of AI for automated medical image analysis for better management of various health conditions including, kidney/breast/skin cancer, glaucoma, psoriasis. She worked on various research projects including event detection in social media streams, AI for automatic systematic reviews, cancer segmentation and classification, disease severity assessment and lesion detection using different data modalities (text, numerical, 2D images, and 3D volumes). Her research work is recognised through serval research publications, 2 patents, several invited talks, and prestigious research grants. Her research interests include AI, data science, NLP, computer vision, and medical image analytics across domains of radiology, pathology, dermatology, and ophthalmology.

See Full Profile

Anil Kumar

University of Georgia (UGA), USA
Most Relevant Research Interests
Nephrology
Other Research Interests (58)
Biomedical Engineer | Biomaterials | Cancer Therapeutics | Anti-Microbial Therapy | Medical Devices | Regulatory Toxicolog
Applied Microbiology and Biotechnology
Bioengineering
Biotechnology
Biophysics
And 53 more
Most Relevant Publications (1+)

90 total publications

Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins

Kidney International / Nov 01, 1995

Kanwar, Y. S., Liu, Z. Z., Kumar, A., Wada, J., & Carone, F. A. (1995). Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney International, 48(5), 1646–1659. https://doi.org/10.1038/ki.1995.460

See Full Profile

Mehrdad Sheikhvatan

Iran University of Medical Sciences
Most Relevant Research Interests
Nephrology
Other Research Interests (48)
Obstetrics and Gynecology
Neurology (clinical)
Otorhinolaryngology
Gastroenterology
Hepatology
And 43 more
Most Relevant Publications (1+)

90 total publications

The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis

Journal of Nephropharmacology / Jul 27, 2018

Sheikhvatan, M., Ataei, Z., Heydari, A., & Zahergivar, A. (2018). The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis. Journal of Nephropharmacology, 7(2), 164–168. https://doi.org/10.15171/npj.2018.32

See Full Profile

Dr. Craig Pfeifer PhD, ATC, FHEA

Most Relevant Research Interests
Nephrology
Other Research Interests (7)
Injury Prevention
Health-related Fitness
Motor skill performance
motor behavior
Orthopedics and Sports Medicine
And 2 more
Most Relevant Publications (1+)

20 total publications

Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance

Research Quarterly for Exercise and Sport / Aug 23, 2019

Sacko, R., McIver, K., Brazendale, K., Pfeifer, C., Brian, A., Nesbitt, D., & Stodden, D. F. (2019). Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance. Research Quarterly for Exercise and Sport, 90(4), 629–640. https://doi.org/10.1080/02701367.2019.1642440

See Full Profile

Example nephrology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on nephrology?

Drug Development for Kidney Diseases

A pharmaceutical company can collaborate with a nephrology researcher to develop new drugs for kidney diseases. The researcher's expertise in understanding the underlying mechanisms of kidney diseases and their experience in conducting clinical trials can greatly contribute to the development of effective and safe medications.

Medical Device Innovation

A medical device company can partner with a nephrology expert to innovate and improve devices used in dialysis treatments. The researcher's knowledge of dialysis procedures and patient needs can help in designing more efficient and user-friendly devices, leading to better treatment outcomes and enhanced patient experience.

Precision Medicine in Nephrology

A biotech company can collaborate with a nephrology researcher to develop personalized treatment approaches for kidney diseases. By analyzing genetic and molecular data, the researcher can identify biomarkers and genetic variants that influence disease progression and response to treatment, enabling the development of targeted therapies for individual patients.

Telemedicine Solutions for Nephrology

A healthcare technology company can work with a nephrology expert to develop telemedicine solutions for remote monitoring and management of kidney diseases. The researcher's understanding of the unique challenges faced by nephrology patients and their expertise in leveraging technology can help in creating user-friendly platforms that improve access to care and enable timely interventions.

Clinical Trials and Research Collaborations

Companies involved in clinical research can collaborate with nephrology researchers to conduct clinical trials and studies related to kidney diseases. The researcher's knowledge of disease mechanisms, patient populations, and research methodologies can contribute to the successful execution of trials, leading to the development of evidence-based treatments and therapies.